Placenta-Derived ECFCs Offer Great Promise For Stem Cell Therapy
7/23/2012
A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic...
Not all adult stem cells are created equal. Some are busy regenerating worn out or damaged tissues, while their quieter brethren serve as a strategic back-up crew that only steps in when demand shoots up...
Hundreds Of Random Mutations In Leukemia Linked To Aging, Not Cancer
7/22/2012
Hundreds of mutations exist in leukemia cells at the time of diagnosis, but nearly all occur randomly as a part of normal aging and are not related to cancer, new research shows. Scientists at Washington University School of Medicine in St. Louis have found that even in healthy people, stem cells in the blood routinely accumulate new mutations over the course of a person's lifetime...
Blocking IL-6 Improved Response To Breast Cancer Drug Herceptin
7/22/2012
Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant...
PSA Prostate Cancer Screening For Men With Long Life Expectancies
7/21/2012
Doctors should discuss with their patients fully the risks and benefits of PSA prostate cancer screening if the patient has a life expectance of more than ten years, an ASCO (American Society of Clinical Oncology) Panel advised today in a new evidence-based PCO (provisional clinical opinion)...
Consuming Vitamin E Lowers Chance Of Liver Cancer
7/21/2012
Individuals could reduce their risk of developing liver cancer by consuming more vitamin E, either from diet or vitamin supplements, according to a new study.` According to the study, published in the Journal of the National Cancer Institute, liver cancer is one of the leading causes of cancer mortality in world...
Bladder Cancer Drug Instiladrin™ Enters Phase II Trial After Being Cleared By FDA And RAC
7/21/2012
FKD Therapies Oy ('FKD' or the 'Company') has announced that it has received clearance from the United States (US) Food and Drug Administration (FDA) and the US Recombinant Advisory Committee (RAC) allowing it to commence a Phase II trial for Instiladrin™ in the US...
Cell Glue Gives Insights Into Cancer
7/21/2012
University of Queensland researchers have discovered an important step in how proteins glue cells together to form healthy tissues, a process that is often disturbed in diseases such as cancer and inflammation...
New Study Reveals Racial Disparities In Voice Box-Preserving Cancer Treatment
7/21/2012
A new epidemiological study led by UC Davis researchers reveals significant racial disparities in the use of non-surgical larynx-preservation therapy for locally advanced laryngeal cancer...
Improved Survival For Patients With Chronic Blood Diseases
7/21/2012
New research from Karolinska Institutet shows that the survival for patients with chronic myeloproliferative diseases has improved in recent decades. This is despite the fact that no targeted drugs have yet been registered for this group of diseases. More than 9,000 patients have been included in a unique population-based study which has been published in the Journal of Clinical Oncology...